In this expert perspective from Retina 2026, Sunir J. Garg, MD, FACS, FASRS, discusses how real-world data have advanced treatment of retinal vascular diseases by increasing the number of available ...
The FDA cleared an investigational new drug application for NTX-1024 ophthalmic solution in vernal keratoconjunctivitis, ...
Julie Rosenthal, MD, MS, discusses the future direction of research into treating age-related macular degeneration.
Phentolamine is framed as a differentiated, preservative-free sympatholytic approach that modulates pupil dynamics without ciliary muscle activation, targeting near-vision improvement while ...
A pair of phase 3 clinical trial results show favorable safety and IOP-lowering effects in glaucoma and ocular hypertension.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results